ClinicalTrials.gov
ClinicalTrials.gov Menu

ActiveCare+SFT Hemodynamic Profile Compare to SCD Express in Ventilated Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00338819
Recruitment Status : Unknown
Verified June 2006 by Tel-Aviv Sourasky Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : June 20, 2006
Last Update Posted : June 20, 2006
Sponsor:
Information provided by:
Tel-Aviv Sourasky Medical Center

Brief Summary:

Purpose:

To test the hemodynamic profile generated by the MCS’s ActiveCare+SFT device in ventilated patients and compare it to that of the Kendall SCD Express.

Design:

Comparative, prospective study. Patients are their own controls.


Condition or disease
DVT Prevention Ventilated Patients

Study Type : Observational
Observational Model: Defined Population
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: ActiveCare+SFT Hemodynamic Profile Compare to SCD Express in Ventilated Patients




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult ventilated patient (Age >18).
  • The patient or his guardian is able and voluntarily prepared to sign the Informed Consent Form.

Exclusion Criteria:

  • Known, preexisting DVT or PE.
  • Patient who is participating in another clinical trial.
  • Patient with contraindication to use of the device including patients with leg gangrene, recent skin graft or medical situations where increase venous and lymphatic return is undesirable.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00338819


Contacts
Contact: Sorkine, Prof 972-3-6973894 sorkine@tasmc.health.gov.il

Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Investigators
Principal Investigator: Sorkine, Prof Tel-Aviv Sourasky Medical Center

ClinicalTrials.gov Identifier: NCT00338819     History of Changes
Other Study ID Numbers: TASMC06SP156CTIL
First Posted: June 20, 2006    Key Record Dates
Last Update Posted: June 20, 2006
Last Verified: June 2006

Keywords provided by Tel-Aviv Sourasky Medical Center:
DVT prevention
Hemodynamic study
IPC
CECT